News Conference News ESC 2025 NEWTON-CABG CardioLink-5: Evolocumab Doesn’t Prevent SVG Failure Michael O'Riordan September 04, 2025
News Conference News AHA 2024 GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes Michael O'Riordan November 17, 2024
News Conference News EACTS 2024 Will Semaglutide Change Cardiac Surgery? It Already Has Yael L. Maxwell October 10, 2024
News Conference News ESC 2023 STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function Shelley Wood August 25, 2023
News Conference News ACC 2023 Diabetic Patients in Middle East, Africa Overburdened by ASCVD Michael O'Riordan March 14, 2023
News Conference News AHA 2021 No Mortality Difference Between PCI and CABG for Left Main CAD: Meta-analysis Michael O'Riordan November 15, 2021
News Conference News AHA 2021 PALACS: Posterior Left Pericardiotomy Cuts Postop AF After Cardiac Surgery Todd Neale November 14, 2021
News Conference News AHA 2020 Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials Michael O'Riordan November 17, 2020
News Conference News AHA 2020 High Burden of Post-CABG A-fib After Hospital Discharge: SEARCH-AF Michael O'Riordan November 16, 2020
News Conference News SCAI 2020 Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data Caitlin E. Cox May 15, 2020
News Conference News AHA 2019 No Benefit of Colchicine in All-Comers PCI Shelley Wood November 17, 2019
News Conference News ESC 2019 DAPA-HF Details: Dapagliflozin Slashes HF Outcomes, Even in Nondiabetics Shelley Wood September 01, 2019
News Conference News ACC 2019 New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin Shelley Wood March 26, 2019
News Conference News AHA 2018 EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits Michael O'Riordan November 16, 2018
News Conference News AHA 2018 Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT Michael O'Riordan November 10, 2018
News Conference News AHA 2017 Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events Michael O'Riordan November 17, 2017